在暴露于脂多糖糖体后,BV2细胞中免疫相关的转录和表观遗传重构:一个体外奥米克综合性研究
Arturo Marroquín-Rivera1,2, Chenqi Zhao1, André Moreira Pessoni1,2
1CERVO Brain Research Center, Québec City, QC, Canada.
概括
微质中的表观遗传重构驱动炎症反应. 基因突变和基因表达的变化揭示了炎症研究的新目标.
科学领域:
- 神经免疫学 神经免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 微质在神经炎症中发挥着关键作用,它们的亲或抗炎性表型可能由表观遗传机制调节.
- 在炎症期间表观遗传标记控制基因表达的精确机制在很大程度上是未知的.
研究的目的:
- 在炎症反应期间调查微质细胞的表观遗传景观.
- 了解基因组修饰如何调节基因表达,以应对脂多糖 (LPS).
主要方法:
- 在LPS暴露和控制微质细胞中使用CUT&RUN对四种基因组标记 (H3K4me1,H3K4me3,H3K27ac,H3K27me3) 进行全基因组分析.
- RNA测序 (RNA-seq) 用于确定转录基因特征和识别差异表达基因.
- 结合表观遗传和转录基因数据以确定全基因组变化及其功能关联.
主要成果:
- 暴露于LPS诱导了M1微细胞表型,通过转录组分析证实了炎症基因 (例如TNF-α,IL-6) 的上调.
- 基因组修饰模式显示与炎症基因相关的差异性结合区域,与它们的调节作用一致.
- 整合omics数据揭示了8种不同的染色质状态,这些染色质在LPS治疗后发生了变化,与特定的基因表达集群和生物功能相关,包括炎症反应激活.
结论:
- 在LPS治疗和控制微质细胞之间观察到基因组修饰分布的显著差异,表明表观遗传重构驱动炎症.
- 这项研究强调了组织蛋白修饰在炎症期间基因表达中的调节作用.
- 这些发现为神经炎症疾病的未来研究和治疗策略提供了潜在的目标.
相关概念视频
02:28Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
01:24B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K